From metabolic markers to hormone health, The Longevity Center offers personalized strategies rooted in data, not guesswork GREENVILLE, SC / ACCESS Newswire / October 2, 2025 / The Longevity Center, ...

Volition's Nu.Q® Discover program enables drug developers and scientists access to a range of state-of-the-art assays for rapid epigenetic profiling in disease model development, preclinical testing, ...

Atlanta Business Chronicle Market President and Publisher David Rubinger sat down with healthcare leaders at Wellstar and ...

Avacta is slated to present the final Phase Ia dose escalation data for our lead program, faridoxorubicin. This will be at ESMO 2025 in Berlin, a little bit later next month in October of 2025. There, ...

From policy to personnel, the former prime minister’s influence is everywhere, says Anne McElvoy. But is it something to be welcomed or be wary about – and what could it mean going forward?

Microsoft is taking a big step forward with major updates to our individual subscription lineup, combining the best of AI and ...

Malaria treatment failures associated with reduced efficacy of chloroquine (CQ) and amodiaquine (AQ) antimalarial drugs ...

Making Work Work Smarter HP Workforce Experience Platform (WXP) 9 is a digital ecosystem that brings together all of HP’s software and services capabilities into one AI-powered, cloud-based platform ...

Once enabled, Claude gains access to a private computer environment where it can write code and run programs to create the files you need. This represents a significant expansion ...

McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease ...